ATOSSA THERAPEUTICS, INC. Annual Income Tax Expense (Benefit) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Atossa Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2011 to 2023.
  • Atossa Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $0.000.
  • Atossa Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $0.000.
  • Atossa Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Atossa Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Atossa Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-Q 2024-05-13
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 $0 $0 Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 $0 Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2016-03-30
2014 $0 $0 Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 $0 $0 Jan 1, 2013 Dec 31, 2013 10-K 2015-03-30
2012 $0 $0 Jan 1, 2012 Dec 31, 2012 10-K 2014-03-27
2011 $0 Jan 1, 2011 Dec 31, 2011 10-K 2013-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.